Oscar Health
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Oscar Health generated cash of -$272,159,000, which is less than the previous year. Cash used in financing activities reached the amount of $6,446,000 last year. Net change in cash is therefore $311,474,000.
Cash Flow
| 2019 | -165.37M | 150.51M | -2.11M |
|---|---|---|---|
| 2020 | 222.73M | -344.71M | 611.70M |
| 2021 | -181.74M | -774.51M | 1.23B |
| 2022 | 380.34M | -226.51M | 301.11M |
| 2023 | -272.15M | 577.18M | 6.44M |
OSCR Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 1.58B | 1.12B | 843.10M | 353.38M | 370.35M |
Operating activities | |||||
Net income | -270.72M | -609.55M | -571.42M | -406.82M | -261.18M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 30.69M | 15.28M | 14.60M | 11.28M | 6.89M |
Stock-based compensation expense | 159.68M | 112.32M | 86.29M | 35.86M | 33.55M |
| Deferred income tax benefit | 159.68M | 112.32M | 86.29M | 35.86M | 33.55M |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 636.22M | -538.95M | 80.45M | -98.58M | -314.31M |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -395.80M | 280.22M | -39.46M | -13.39M | 282.13M |
Cash generated by operating activities | -272.15M | 380.34M | -181.74M | 222.73M | -165.37M |
Investing activities | |||||
Purchases Of Investments | -836.98M | -1.19B | -1.81B | -1.00B | -877.67M |
Investments In Property Plant And Equipment | -25.57M | -29.01M | -25.88M | -14.02M | -25.99M |
Acquisitions Net | 0 | 0 | 7.23M | 0 | 0 |
Cash generated by investing activities | 577.18M | -226.51M | -774.51M | -344.71M | 150.51M |
Financing activities | |||||
Common Stock Issued | 0 | 1.29M | 1.39B | 469.54M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | -2.99M |
Repayments of term debt | 0 | 305M | -153.17M | -142.16M | 0 |
Cash used in financing activities | 6.44M | 301.11M | 1.23B | 611.70M | -2.11M |
Net Change In Cash | 311.47M | 454.94M | 282.45M | 489.72M | -16.97M |
Cash at end of period | 1.89B | 1.58B | 1.12B | 843.10M | 353.38M |
| Data source | Data source | Data source |